1-9 of 9
chlorambucil/prednisone/procarbazine/vinblastine
Close
Sort by
Journal Articles

Tolerability and Efficacy of Treatments in Elderly Patients with Hodgkin Lymphoma: A Report from the Nebraska Lymphoma Study Group

Roberto A. Ferro, MD, Vijaya R. Bhatt, MD, Martin Bast, BS, Lynette Smith, MS, R. Gregory Bociek, MD, Matthew A. Lunning, DO, Philip J Bierman, MD, Julie M. Vose, MD, James O. Armitage, MD
Journal: Blood
Blood (2015) 126 (23): 1504.
https://doi.org/10.1182/blood.V126.23.1504.1504
Published: 2015
Journal Articles

Outcome of Lymphocyte Predominant Hodgkin Lymphoma

Arifa Khalid, Huma Zafar, Rabia Wali, Shazia Riaz, MD, Farhana Badar
Journal: Blood
Blood (2014) 124 (21): 5463.
https://doi.org/10.1182/blood.V124.21.5463.5463
Published: 2014
Journal Articles

Pediatric Hodgkin Lymphoma-Treatment Outcome with COPDac/ABVD Combination Chemotherapy – Single Institution Experience

Mehboob Ahmed, Shazia Riaz, MD, Syed Nasir Abbas, Fahim Rehman
Journal: Blood
Blood (2014) 124 (21): 5449.
https://doi.org/10.1182/blood.V124.21.5449.5449
Published: 2014
Journal Articles

Pediatric Hodgkin’s Lymphoma: 5-Year Experience at Single Center in Pakistan

Shazia Riaz, MD, Safia Khan, MBBS, FCPS pediatrics, Farhana Badar
Journal: Blood
Blood (2014) 124 (21): 5455.
https://doi.org/10.1182/blood.V124.21.5455.5455
Published: 2014
Journal Articles

Serum CD163 and TARC in Combination As Disease Response Biomarkers in Classical Hodgkin Lymphoma

Maher K Gandhi, PhD, FRACP, FRCPath, FRCP, Frank Vari, Phd, Pauline Crooks, Colm Keane, MB BCh BAO MSc MRCPI FRCPath, Jamie P Nourse, PhD, Louise A Seymour, MBBS, FRCPA, David Ritchie, MB, PhD, FRACP, FRCPA, David Gottlieb, MB, PhD, FRCPA, FRACP, Devinder Gill, MB, FRCPath, FRACP, FRCPA, Kimberley Jones, BSc
Journal: Blood
Blood (2012) 120 (21): 49.
https://doi.org/10.1182/blood.V120.21.49.49
Published: 2012
Journal Articles

Multicenter Analysis of Elderly Hodgkin Lymphoma (eHL): Outcomes and Prognostic Factors in the Modern Era

Andrew M. Evens, DO, MSc, Irene Helenowski, MS, Chadi Nabhan, MD, FACP, Erika Ramsdale, MD, June M McKoy, MD, JD, MPH, MBA, Annette Larsen, B.A., R.N., Sarah Miyata, RN, MSN, ACNP, Benjamin Parsons, DO, Reem Karmali, MD, Britt E. Hanson, DO, Leo I. Gordon, MD, FACP, Scott E. Smith, MD, PhD, FACP, Stephanie A. Gregory, MD, Sonali M. Smith, MD
Journal: Blood
Blood (2011) 118 (21): 2625.
https://doi.org/10.1182/blood.V118.21.2625.2625
Published: 2011
Journal Articles

Outcome of Patients with Advanced Hodgkin Lymphoma Who Are Either Refractory to or Relapsed After Primary Therapy with the Stanford V Regimen

Lauren S. Maeda, MD, Richard T. Hoppe, MD, Saul A. Rosenberg, MD, Sandra J. Horning, MD, Ranjana H. Advani, MD
Journal: Blood
Blood (2010) 116 (21): 4828.
https://doi.org/10.1182/blood.V116.21.4828.4828
Published: 2010
Journal Articles

A Single-Centre Analysis by Intention to Treat with High Dose Chemotherapy and Autologous Stem Cell Rescue Following Second-Line Treatment In Patients with Hodgkin Lymphoma

Paul Greaves, Andrew Wilson, Janet Matthews, Daniel L P Brown, Silvia Montoto, MD, John G. Gribben, MD, DSc, Andrew Lister, MD
Journal: Blood
Blood (2010) 116 (21): 2388.
https://doi.org/10.1182/blood.V116.21.2388.2388
Published: 2010
Journal Articles

Consolidation Radiotherapy Is Associated with Improved Outcomes after Chemotherapy for Advanced Hodgkin Lymphoma: Analysis of Results from the UKLG LY09 Trial (ISRCTN97144519)

Peter W.M. Johnson, MD, FRCP, Matthew R Sydes, John Radford, MD, FRCP, Michael Cullen, MD, FRCP, Sally Stenning, Barry Hancock, MD, FRCP
Journal: Blood
Blood (2008) 112 (11): 368.
https://doi.org/10.1182/blood.V112.11.368.368
Published: 2008